(Q43998820)

English

Hyperaminoaciduria identifies patients at risk of developing renal tubular toxicity associated with ifosfamide and platinate containing regimens

scientific article published on January 1, 1992

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Hyperaminoaciduria identifies patients at risk of developing renal tubular toxicity associated with ifosfamide and platinate containing regimens (English)

1 reference

10.1002/MPO.2950200109

https://api.crossref.org/works/10.1002/MPO.2950200109

9 November 2022

1 reference

based on heuristic

inferred from title

1 reference

10.1002/MPO.2950200109

https://api.crossref.org/works/10.1002/MPO.2950200109

9 November 2022

author name string

van Gennip A

3

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

de Kraker J

4

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Voûte PA

5

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

H. N. Caron

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1727210

9 November 2022

N. Abeling

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1727210

9 November 2022

A. van Gennip

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1727210

9 November 2022

J. de Kraker

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1727210

9 November 2022

P. A. Voûte

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1727210

9 November 2022

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 1992

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fmpo.2950200109

1 reference

10.1002/MPO.2950200109

https://api.crossref.org/works/10.1002/MPO.2950200109

9 November 2022

https://onlinelibrary.wiley.com/doi/full/10.1002/mpo.2950200109

1 reference

10.1002/MPO.2950200109

https://api.crossref.org/works/10.1002/MPO.2950200109

9 November 2022

Pediatric Blood & Cancer

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Medical and Pediatric Oncology

20

1

42–7

publication date

1992

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1727210

9 November 2022

20

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

42-47

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Ifosfamide--pharmacology, safety and therapeutic potential

1

1 reference

10.1002/MPO.2950200109

https://api.crossref.org/works/10.1002/MPO.2950200109

9 November 2022

The role of ifosfamide in paediatric soft tissue sarcomas

5

1 reference

10.1002/MPO.2950200109

https://api.crossref.org/works/10.1002/MPO.2950200109

9 November 2022

Central nervous system toxicity following the treatment of pediatric patients with ifosfamide/mesna

6

1 reference

10.1002/MPO.2950200109

https://api.crossref.org/works/10.1002/MPO.2950200109

9 November 2022

Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention--III. Profile of action of sodium 2-mercaptoethane sulfonate (mesna)

8

1 reference

10.1002/MPO.2950200109

https://api.crossref.org/works/10.1002/MPO.2950200109

9 November 2022

Cancer chemotherapy reports

9

58

375

author name string

DeFronzo

publication date

1974

1 reference

10.1002/MPO.2950200109

https://api.crossref.org/works/10.1002/MPO.2950200109

9 November 2022

Failure of 2-mercaptoethane sulphonate sodium (mesna) to protect against ifosfamide nephrotoxicity

10

1 reference

10.1002/MPO.2950200109

https://api.crossref.org/works/10.1002/MPO.2950200109

9 November 2022

Cancer Treatment Reports

11

71

127

author name string

Goren

publication date

1987

1 reference

10.1002/MPO.2950200109

https://api.crossref.org/works/10.1002/MPO.2950200109

9 November 2022

Nephrotoxicity associated with ifosfamide

12

1 reference

10.1002/MPO.2950200109

https://api.crossref.org/works/10.1002/MPO.2950200109

9 November 2022

Ifosfamide-induced renal tubular defects

13

1 reference

10.1002/MPO.2950200109

https://api.crossref.org/works/10.1002/MPO.2950200109

9 November 2022

Hypophosphataemic rickets after ifosfamide treatment in children

14

1 reference

10.1002/MPO.2950200109

https://api.crossref.org/works/10.1002/MPO.2950200109

9 November 2022

Fanconi syndrome after ifosfamide

15

1 reference

10.1002/MPO.2950200109

https://api.crossref.org/works/10.1002/MPO.2950200109

9 November 2022

Identifiers

10.1002/MPO.2950200109

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43998820&oldid=1768219487"